|
|
 |
|
Viewing report
|
|
|
|
Kosan Biosciences, Inc:Premium Company Profile
Datamonitor, Dec 2007, Pages: 50
Introduction
Kosan Biosciences is a cancer therapeutics company engaged in advancing two new classes of anti-cancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones. The companys proprietary technologies, utilized for developing polyketides, have resulted in a potential product pipeline for the company in the oncology field.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Kosan Biosciences currently has no marketed products. The companys product portfolio includes five potential candidates in development. These include: Tanespimycin, for the treatment of relapsed-refractory multiple myeloma, metastatic melanoma and HER2-positive metastatic breast cancer. Alvespimycin, being developed in intravenous and oral dosage forms for the treatment of HER2-positive metastatic breast cancer and solid tumors; KOS-1584, for the treatment of advanced solid tumors; and KOS-2187, for the treatment of gastrointestinal motility disorders such as gastroparesis and gastroesophageal reflux disease (GERD). The companys total revenues increased at a CAGR of 8.9% during 2002-2006, from $9.6 million to $13.5 million. This represents an absolute total growth of +$3.9 million for total revenues. The companys only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand companys strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to companys adjusted five year financial data along with key ratios and market capitalization
Customers who bought this item also bought
Idemitsu Kosan Co. Ltd. Refining Operation Asset Summary Report
Idemitsu Kosan Co., Ltd. Oil and Gas Assets Report
Idemitsu Kosan Co., Ltd. Analysis Across The Oil and Gas Value Chain
Idemitsu Kosan Co., Ltd. Detailed Analysis and Forecasts of Oil & Gas Exploration and Production Assets
Idemitsu Kosan Co., Ltd. - SWOT Analysis
Idemitsu Kosan Co., Ltd. - Financial and Strategic Analysis Review
Idemitsu Kosan Co., Ltd. - Energy Oil & Gas SWOT Report
Idemitsu Kosan Co. Ltd. Tanker Operation Asset Summary Report
Fuji Kosan Company, Ltd.
Joban Kosan Co., Ltd.
Idemitsu Kosan Co Ltd 2009 Fortune Global 500 Snapshot Company Profile
Business Update Call - Kosan Biosciences, Inc. - Earnings Transcript
|
|
|
|
